The role of colchicine on ventricular remodelling following myocardial infarction and ischemia-reperfusion injury: article review

Fahreza Caesario, Indra Prasetya

Abstract


Acute myocardial infarction (AMI) is a major cause of cardiac dysfunction, arrhythmias, and a poor prognosis. Even though new technologies have been developed to aid in opening the culprit coronary artery and correcting ischemia-related stenosis by percutaneous coronary intervention (PCI), the ventricular remodelling that induces cardiac failure as a consequence of AMI remains unchanged. Colchicine, a versatile anti-inflammatory medication, has been documented in mitigating cardiac remodelling and enhancing cardiac function following AMI. This article provides an in-depth review of the processes by which colchicine affects ventricular remodeling after AMI, highlighting the potential role of inflammation in the pathogenesis and progression of ventricular dysfunction.


Keywords


Colchicine; Ischemia-Reperfusion Injury; Myocardial Infarction Ventricular Remodelling

Full Text:

PDF

References


Leancă SA, Crișu D, Petriș AO, et al. Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment. Life. 2022;12(8):1111. doi:10.3390/life12081111

Akodad M, Sicard P, Fauconnier J, Roubille F. Colchicine and myocardial infarction: A review. Arch Cardiovasc Dis. 2020;113(10):652-659. doi:10.1016/j.acvd.2020.04.007

Mewton N, Roubille F, Bresson D, et al. Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction. Circulation. 2021;144(11):859-869. doi:10.1161/CIRCULATIONAHA.121.056177

Li Y wei, Chen S xu, Yang Y, et al. Colchicine Inhibits NETs and Alleviates Cardiac Remodeling after Acute Myocardial Infarction. Cardiovasc Drugs Ther. Published online July 28, 2022. doi:10.1007/s10557-022-07326-y

Frangogiannis NG. Pathophysiology of Myocardial Infarction. In: Comprehensive Physiology. Wiley; 2015:1841-1875. doi:10.1002/cphy.c150006

Saleh M, Ambrose JA. Understanding myocardial infarction. F1000Res. 2018;7:1378. doi:10.12688/f1000research.15096.1

Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20). doi:10.1161/CIR.0000000000000617

Surendran A, Atefi N, Zhang H, Aliani M, Ravandi A. Defining Acute Coronary Syndrome through Metabolomics. Metabolites. 2021;11(10):685. doi:10.3390/metabo11100685

Al-Botaty B, El-Khoely A, Elsayed E, Eissa A. Insight into the Pathophysiology of Myocardial Infarction. Journal of Advanced Pharmacy Research. 2022;6(4):223-237. doi:10.21608/aprh.2022.155725.1188

Frangogiannis NG. Pathophysiology of Myocardial Infarction. In: Comprehensive Physiology. Wiley; 2015:1841-1875. doi:10.1002/cphy.c150006

Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-3826. doi:10.1093/eurheartj/ehad191

Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. Published online June 26, 2016:ehw224. doi:10.1093/eurheartj/ehw224

Stone GW, Selker HP, Thiele H, et al. Relationship Between Infarct Size and Outcomes Following Primary PCI. J Am Coll Cardiol. 2016;67(14):1674-1683. doi:10.1016/j.jacc.2016.01.069

Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. Journal of Clinical Investigation. 2013;123(1):92-100. doi:10.1172/JCI62874

Yamada K, Mizutani Y, Nakamura H, Ukaji T, Sato H, Koshikawa Y. Reperfusion Injury after Acute Myocardial Infarction. Dokkyo Medical Journal. 2022;1(4):274-284.

Schirone L, Forte M, D’Ambrosio L, et al. An Overview of the Molecular Mechanisms Associated with Myocardial Ischemic Injury: State of the Art and Translational Perspectives. Cells. 2022;11(7):1165. doi:10.3390/cells11071165

Algoet M, Janssens S, Himmelreich U, et al. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med. 2023;33(6):357-366. doi:10.1016/j.tcm.2022.02.005

Zhao W, Zhao J, Rong J. Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction. Oxid Med Cell Longev. 2020;2020:1-11. doi:10.1155/2020/8815349

Leancă SA, Crișu D, Petriș AO, et al. Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment. Life. 2022;12(8):1111. doi:10.3390/life12081111

Yalta K, Yilmaz MB, Yalta T, Palabiyik O, Taylan G, Zorkun C. Late Versus Early Myocardial Remodeling After Acute Myocardial Infarction: A Comparative Review on Mechanistic Insights and Clinical Implications. J Cardiovasc Pharmacol Ther. 2020;25(1):15-26. doi:10.1177/1074248419869618

Bhatt AS, Ambrosy AP, Velazquez EJ. Adverse Remodeling and Reverse Remodeling After Myocardial Infarction. Curr Cardiol Rep. 2017;19(8):71. doi:10.1007/s11886-017-0876-4

González L, Bulnes JF, Orellana MP, Muñoz Venturelli P, Martínez Rodriguez G. The Role of Colchicine in Atherosclerosis: From Bench to Bedside. Pharmaceutics. 2022;14(7):1395. doi:10.3390/pharmaceutics14071395

Imazio M, Nidorf M. Colchicine and the heart. Eur Heart J. 2021;42(28):2745-2760. doi:10.1093/eurheartj/ehab221

Deftereos S, Giannopoulos G, Angelidis C, et al. Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction. Circulation. 2015;132(15):1395-1403. doi:10.1161/CIRCULATIONAHA.115.017611

Cole J, Htun N, Lew R, Freilich M, Quinn S, Layland J. Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial. Circ Cardiovasc Interv. 2021;14(5). doi:10.1161/CIRCINTERVENTIONS.120.009992

Deftereos S, Giannopoulos G, Angelidis C, et al. Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction. Circulation. 2015;132(15):1395-1403. doi:10.1161/CIRCULATIONAHA.115.017611

Zhang F shun, He Q ze, Qin CH, Little PJ, Weng J ping, Xu S wen. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review. Acta Pharmacol Sin. 2022;43(9):2173-2190. doi:10.1038/s41401-021-00835-w

Saji K, Fukumoto Y, Suzuki J, Fukui S, Nawata J, Shimokawa H. Colchicine, a Microtubule Depolymerizing Agent, Inhibits Myocardial Apoptosis in Rats. Tohoku J Exp Med. 2007;213(2):139-148. doi:10.1620/tjem.213.139

Prins KW, Tian L, Wu D, Thenappan T, Metzger JM, Archer SL. Colchicine Depolymerizes Microtubules, Increases Junctophilin‐2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension. J Am Heart Assoc. 2017;6(6). doi:10.1161/JAHA.117.006195

Bakhta O, Blanchard S, Guihot AL, et al. Cardioprotective Role of Colchicine Against Inflammatory Injury in a Rat Model of Acute Myocardial Infarction. J Cardiovasc Pharmacol Ther. 2018;23(5):446-455. doi:10.1177/1074248418763611

Akodad M, Fauconnier J, Sicard P, et al. Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model. Int J Cardiol. 2017;240:347-353. doi:10.1016/j.ijcard.2017.03.126

Fujisue K, Sugamura K, Kurokawa H, et al. Colchicine Improves Survival, Left Ventricular Remodeling, and Chronic Cardiac Function After Acute Myocardial Infarction. Circulation Journal. 2017;81(8):1174-1182. doi:10.1253/circj.CJ-16-0949

Hennessy T, Soh L, Bowman M, et al. The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction. Am Heart J. 2019;215:62-69. doi:10.1016/j.ahj.2019.06.003

Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. New England Journal of Medicine. 2019;381(26):2497-2505. doi:10.1056/NEJMoa1912388




DOI: https://doi.org/10.21776/ub.hsj.2024.005.04.3

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Fahreza Caesario, Indra Prasetya

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.